MX2017014195A - Hidrogenacion de aceite de cannabis. - Google Patents

Hidrogenacion de aceite de cannabis.

Info

Publication number
MX2017014195A
MX2017014195A MX2017014195A MX2017014195A MX2017014195A MX 2017014195 A MX2017014195 A MX 2017014195A MX 2017014195 A MX2017014195 A MX 2017014195A MX 2017014195 A MX2017014195 A MX 2017014195A MX 2017014195 A MX2017014195 A MX 2017014195A
Authority
MX
Mexico
Prior art keywords
hydrogenated
acid
hydrogenation
cannabis
cannabis oil
Prior art date
Application number
MX2017014195A
Other languages
English (en)
Inventor
Andrew Scialdone Mark
Original Assignee
Andrew Scialdone Mark
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrew Scialdone Mark filed Critical Andrew Scialdone Mark
Publication of MX2017014195A publication Critical patent/MX2017014195A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención actual se refiere a la extracción e hidrogenación de aceite esencial de una planta de cannabis. La invención incluye compuestos y composiciones de cannabis hidrogenado, así como métodos de preparación y usos terapéuticos para revertir tumores en un paciente con cáncer. El extracto puede incluir ácido 9-tetrahidrocannabinoico y ácido 9-cannabidiólico, y el aceite de cannabis hidrogenado puede incluir ácido 9-tetrahidrocannabinoico hidrogenado, ácido 9-cabanodiálico hidrogenado, y mezclas y combinaciones de los mismos.
MX2017014195A 2015-05-07 2016-05-09 Hidrogenacion de aceite de cannabis. MX2017014195A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562158025P 2015-05-07 2015-05-07
PCT/US2016/031441 WO2016179581A1 (en) 2015-05-07 2016-05-09 Hydrogenation of cannabis oil

Publications (1)

Publication Number Publication Date
MX2017014195A true MX2017014195A (es) 2018-08-15

Family

ID=57218412

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017014195A MX2017014195A (es) 2015-05-07 2016-05-09 Hidrogenacion de aceite de cannabis.

Country Status (22)

Country Link
US (3) US9694040B2 (es)
EP (1) EP3291807B1 (es)
JP (1) JP2018515608A (es)
KR (1) KR20180002839A (es)
CN (1) CN107735086A (es)
AU (1) AU2016258208B2 (es)
CA (1) CA2985065A1 (es)
CY (1) CY1122609T1 (es)
DK (1) DK3291807T3 (es)
ES (1) ES2764159T3 (es)
HK (1) HK1251460A1 (es)
HR (1) HRP20192244T1 (es)
HU (1) HUE049872T2 (es)
IL (1) IL255478B (es)
LT (1) LT3291807T (es)
MX (1) MX2017014195A (es)
PT (1) PT3291807T (es)
RS (1) RS59828B1 (es)
RU (1) RU2017142561A (es)
SI (1) SI3291807T1 (es)
WO (1) WO2016179581A1 (es)
ZA (1) ZA201707529B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10319475B1 (en) 2014-06-13 2019-06-11 Enigami Systems, Inc. Method and apparatus for determining relationships between medications and symptoms
US10913071B2 (en) 2016-03-09 2021-02-09 Pearson Incorporated Scalper apparatus and processing system
US10322487B1 (en) 2016-07-15 2019-06-18 Pearson Incorporated Roller mill grinding apparatus with regenerative capability
JP2020515379A (ja) * 2016-12-01 2020-05-28 ナチュラル イクストゥラクション システムズ，エルエルシー マイクロ波剤を利用した急速植物性油蒸留装置
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
WO2018163163A1 (en) * 2017-03-05 2018-09-13 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Compositions and methods for treating inflammatory diseases
CA3056422C (en) * 2017-03-18 2023-05-09 Steven M. McGarrah Pet food including cannabidiolic acid
US10807098B1 (en) 2017-07-26 2020-10-20 Pearson Incorporated Systems and methods for step grinding
US10272360B2 (en) 2017-08-05 2019-04-30 Priya Naturals, Inc. Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto
US20200281890A1 (en) * 2017-09-25 2020-09-10 Canopy Health Innovations Compositions comprising cannabidiol, tetrahydrocannabinol, terpenes, and flavonoids and use thereof in the treatment of insomnia
US11498018B2 (en) 2017-11-27 2022-11-15 Vasilios (Bill) Panagiotakopoulos Extraction and purification of cannabinoid compounds
EP3717093A4 (en) * 2017-11-27 2021-09-15 Beleave Inc. EXTRACTION AND PURIFICATION OF CANNABINOID COMPOUNDS
US10688191B2 (en) 2018-01-19 2020-06-23 Hr Biomed, Llc Delivery of a chemotherapy agent across the blood-brain barrier
WO2019152736A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
CA3006692A1 (en) 2018-05-30 2019-11-30 Kevin Allan Dooley Inc. A system and method for extracting and separating botanical oils without the use of solvents
US11325133B1 (en) 2018-07-26 2022-05-10 Pearson Incorporated Systems and methods for monitoring the roll diameter and shock loads in a milling apparatus
US20200035118A1 (en) 2018-07-27 2020-01-30 Joseph Pandolfino Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
US10897925B2 (en) 2018-07-27 2021-01-26 Joseph Pandolfino Articles and formulations for smoking products and vaporizers
WO2020077153A1 (en) 2018-10-10 2020-04-16 Canopy Holdings, LLC Synthesis of cannabigerol
US10751722B1 (en) 2018-10-24 2020-08-25 Pearson Incorporated System for processing cannabis crop materials
US10785906B2 (en) 2019-02-19 2020-09-29 Pearson Incorporated Plant processing system
CA3150080A1 (en) 2019-09-06 2021-03-11 Michael Dane BACKES OPTIMIZING VOLATILE ENVIRONMENTS IN MIXTURES OF DRIED FLOWER PLANTS
US10757860B1 (en) 2019-10-31 2020-09-01 Hemp Processing Solutions, LLC Stripper apparatus crop harvesting system
US10933424B1 (en) 2019-12-11 2021-03-02 Pearson Incorporated Grinding roll improvements
WO2022115718A1 (en) * 2020-11-29 2022-06-02 Castor Trevor P Extraction, separation and purification of cannabinoids from cannabis staiva and other marijuana biomass
WO2023004414A1 (en) * 2021-07-23 2023-01-26 Colorado Chromatography, Llc A method for preparing hexahydrocannabinol
US11759491B2 (en) 2021-07-30 2023-09-19 Super Critical Ip, Llc Solvents, methods, and systems for isolating botanical extracts from plants
WO2024069589A1 (en) * 2022-09-29 2024-04-04 Blackstone Therapeutics, Llc Cannabinoid analogs and methods of use for treatment and prevention of cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2419937A (en) * 1944-03-27 1947-05-06 Adams Roger Marihuana active compounds
ITMI20070522A1 (it) * 2007-03-16 2008-09-17 Eni Spa Composizione idrocarburica utile come carburante e combustibile contenente una componente petrolifera e una componente di origine biologica
GB2478595B (en) * 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
NL2006621C2 (en) * 2011-04-18 2012-10-22 Fytagoras B V New medical use for acidic cannabinoids.
GB2494461A (en) * 2011-09-12 2013-03-13 Gw Pharma Ltd Phytocannabinoids for use in the treatment of invasive cancers or metastases
CA2866787C (en) * 2011-09-29 2021-05-18 Thc Pharm Gmbh The Health Concept Cannabinoid carboxylic acids, salts of cannabinoid carboxylic acids, and the production and uses of same

Also Published As

Publication number Publication date
IL255478B (en) 2020-11-30
PT3291807T (pt) 2020-01-10
HUE049872T2 (hu) 2020-11-30
HRP20192244T1 (hr) 2020-03-20
ZA201707529B (en) 2018-11-28
LT3291807T (lt) 2020-01-27
JP2018515608A (ja) 2018-06-14
US20160324909A1 (en) 2016-11-10
RS59828B1 (sr) 2020-02-28
DK3291807T3 (da) 2020-01-13
CA2985065A1 (en) 2016-11-10
HK1251460A1 (zh) 2019-02-01
US10071127B2 (en) 2018-09-11
RU2017142561A3 (es) 2019-11-14
CN107735086A (zh) 2018-02-23
SI3291807T1 (sl) 2020-02-28
AU2016258208A1 (en) 2017-11-30
EP3291807B1 (en) 2019-09-25
US9694040B2 (en) 2017-07-04
EP3291807A1 (en) 2018-03-14
IL255478A (en) 2018-01-31
AU2016258208B2 (en) 2021-05-27
ES2764159T3 (es) 2020-06-02
WO2016179581A1 (en) 2016-11-10
US20190030102A1 (en) 2019-01-31
EP3291807A4 (en) 2018-05-16
US20170266245A1 (en) 2017-09-21
CY1122609T1 (el) 2021-03-12
RU2017142561A (ru) 2019-06-10
KR20180002839A (ko) 2018-01-08

Similar Documents

Publication Publication Date Title
MX2017014195A (es) Hidrogenacion de aceite de cannabis.
MX2017016376A (es) Derivado de piperidina y metodo de preparacion y uso farmaceutico del mismo.
MX2021006531A (es) Composicion que contiene arn para tratamiento de enfermedades tumorales.
TW201613901A (en) New compounds
GB201209613D0 (en) New compounds
MX2019001286A (es) Composicion de cannabis.
MX2016002544A (es) Compuestos utiles como inmunomoduladores.
PH12016500094A1 (en) Autotaxin inhibitors
MX356205B (es) Benzopirazinas anticancerigenas via la inhibicion de cinasas del receptor del factor de crecimiento de fibroblasto (fgfr).
JO3419B1 (ar) مركبات بيريدوبيرازين مضادة للسرطان من خلال تثبيط إنزيمات كيناز fgfr
MX2018007844A (es) Derivado de benzopiperidina, metodo de preparacion del mismo y su uso medico del mismo.
MX366899B (es) Nuevos compuestos.
PH12019502363A1 (en) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds
MX2017005578A (es) Métodos de administración de composiciones de amantadina.
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
PH12015502747A1 (en) Novel compounds for the treatment of cancer
MX2021000023A (es) Composicion y metodo para el ahorro de opioides.
MY176521A (en) Pyrrole-substituted indolone derivative, preparation method therefor, composition comprising the same and use thereof
MX2018014129A (es) Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato.
MX2017009608A (es) Compuestos anticancerigenos.
MX2016004094A (es) Composicion farmaceutica que comprende capecitabina y ciclofosfamida.
GB2571050A (en) Use of botanical extracts for improving brain health through enhanced neurogenesis
MX2017007990A (es) Métodos para reducir la agregación plaquetaria y tratar enfermedades cardiovasculares y otros transtornos médicos.
BR112016028017A2 (pt) Inibidor de quinase alk e método de preparação e usos do mesmo